Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era

Table 3 Nagelkerke R square, AUC scores and significance value for logistic regression models 1 to 10 and current Canadian Guidelines

Model	Variables Included	Nagelkerke R Square^a	AUC	p value
Model 1	Asthma, CRSwNP, Eos, LK, LM, SNOT-22	0.355	0.803	0.000
Model 2	Eos, LK, LM, SNOT-22, CRSwNP	0.353	0.795	0.000
Model 3	Asthma, CRSwNP, Eos, LM, SNOT-22	0.353	0.808	0.000
Model 4	CRSwNP, Eos, LM, SNOT-22	0.350	0.796	0.000
Model 5	Asthma, CRSwNP, Eos, SNOT-22	0.343	0.803	0.000
Model 6	Asthma, CRSwNP, Eos, LK, SNOT-22	0.343	0.798	0.000
Model 7	Eos, SNOT-22, CRSwNP, LK	0.341	0.791	0.000
Model 8	Eos, SNOT-22, CRSwNP	0.340	0.795	0.000
Model 9	Asthma, Eos, LM, SNOT-22	0.339	0.799	0.000
Model 10	Asthma, Eos, LK, LM, SNOT-22	0.339	0.800	0.000
Canadian Guidelines	SNOT-22, CRSwNP, LK	0.145	0.691	0.009

^aCloser to 1 the Nagelkerke R square is the better the goodness of fit
CRSwNP, CRS with nasal polyps; Eos, Serum eosinophilia; IgE, I ¹⁸mmunoglobulin E; LK, Lund Kennedy; LM, Lund Mackay; SNOT-22, Sino-nasal Outcome Test 22

ISSN: 1916-0216